HealthQuest participates in $35.5M Series B financing for BardyDx

HealthQuest Capital, River Cities Capital Funds, Aperture Venture Partners, Aphelion Capital and others invested $35.M into BardyDx, a leading provider of ambulatory cardiac monitoring technologies and custom data solutions. The funds will be used to further accelerate growth of its innovative P-wave focused cardiac monitoring platform through expansion of BardyDx's sales force and monitoring services, and to support advanced development programs, including augmented intelligence and visualization technologies.

For more click here